Q&A With Craig Strasnick From Commonwealth Laboratories: New Test Looks for Fast Identification of Irritable Bowel Syndrome

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Craig Strasnick, Chief Operating Officer of Commonwealth Laboratories discussed IBS Check, a new method for diagnosing the condition and separating the two possible diagnoses in an effort to give patients the best results. Strasnick said an "exclusionary pathway" has been used in the past which can often require medical procedures and can take longer before getting the final and correct diagnosis.